2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z

Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.

K. Gutierrez, J. Scheuermann, I. Goldvarg, S. Joshi, G. Tyson, N. Bzowej, N. Girgrah, S. Anders, G. Loss, G. Therapondos.
Safety of a Short (One-Year) Waiting Time in Kidney Transplant Candidates Treated for Cancer.

D. Dahle,¹ T. Grotmol,² T. Leivestad,³ A. Hartmann,¹ G. Mjøen,¹ H. Pihlstrøm,¹ H. Næss,¹ H. Holdaas.¹
Safety, Efficacy, and Cost Saving Potential of Various Weight-Based Dosing for Thymoglobulin Induction Therapy in Kidney Transplant Recipients.

R. Miller,¹ H. Meadows,¹ S. Strout,¹ T. Veasey,¹ A. Mardis,¹ J. Fleming,¹ C. Mardis,¹ N. Pilch,¹ K. Chavin,² D. Taber.²
Schisandra Sphenanthera Extract Facilitates Anti-Tuberculosis Treatment Post Renal Transplantation Through Increasing Bioavailability of Tacrolimus.

R. Deng,¹ L. Zhang,¹ L. Liu,¹ H. Fu,² J. Li,¹ Q. Fu,¹ C. Wang.¹
Selection of Patients with Solitary Lesion of Hepatocellular Cancer for Liver Transplantation.

M. Grąt,¹ J. Stypułkowski,¹ W. Patkowski,¹ K. Wronka,¹ M. Wasilewicz,² K. Grąt,³ L. Masior,¹ M. Krasnodębski,¹ Z. Lewandowski,⁴ M. Krawczyk.¹
Selective Deletion of Notch2 on B Cells Abrogates Alloantibody Production in Fully MHC-Mismatched Cardiac and Skin Transplant Models.

N. Murakami, C. Magee, T. Borges, J. Azzi, L. Riella.
Sepsis Prolongs Allograft Survival Compared with Non-Septic Infection in a Murine Model of Skin Transplantation and Pseudomonas aeruginosa Pneumonia.

L. Margoles, S. Laurie, C. Coopersmith, M. Ford.
Sequential Analysis of Donor-Specific Antibodies and Pathological Findings Using Intravenous Immunoglobulin in a Highly Sensitized Rat Kidney Transplant Model.

Y. Sawada,¹ K. Omoto,² N. Kohei,⁴ K. Kawanishi,³ M. Okumi,² H. Ishida,² T. Kazunari.²
Sequential and Long-Term Protocol Biopsy Is Useful for the Detection of Subclinical Lesions of Clinical Interest in Kidney Allografts.

M. Miura,¹ H. Higashiyama,¹ T. Tsuji,² Y. Fukasawa.²
Serelaxin Decreases the Severity of Cold Ischemia-Reperfusion Injury After Liver Transplantation in Mice.

S. Kageyama, K. Nakamura, R. Busuttil, J. Kupiec-Weglinski.
Serial Peripheral Blood Mononuclear Cell Expression Profiling Reveals Inflammatory Genomic Storm Following Mechanical Circulatory Support Surgery.

G. Godoy,¹ G. Bondar,¹ A. Esmaeili,¹ E. Arellano,¹ E. Chang,¹ M. Bakir,¹ J. Chittoor,¹ R. Togashi,¹ N. Fazli,¹ C. Starling,¹ E. Oh,¹ S. Toluie,¹ Z. Yang,² D. Tran,¹ M. Cadeiras,¹ N. Wisniewski,¹ M. Kwon,¹ J. Schaenman,¹ Y. Korin,¹ M. Rosetti,¹ E. Reed,¹ M. Deng.¹
Serum Albumin Level Has Association with Both Graft Failure and Mortality in Kidney Transplant Recipients.

H. Jeon,¹ S. Rhee,¹ D. Shin,¹ J. Oh,¹ Y. Kim,² J. Lee.³
Serum Bicarbonate and Long-Term Outcomes in Kidney Transplant Recipients.

S. Park,¹ E. Kang,¹ M. Han,¹ J. Park,¹ S. Yang,² S. Park,³ I. Jung,⁴ C. Lim,⁵ Y. Kim,¹ Y. Kim,⁶ J. Lee.⁵
Serum Inflammatory Biomarkers in Kidney Transplant Recipients and Renal Donors.

J. Ramirez,¹ E. Cuevas,¹ J. Furuzawa,² L. Morales-Buenrostro,³ M. Lopez-Cervantes,² J. Alberu.¹
Serum Levels of Soluble Myeloid Antigens After Kidney Allograft Transplantation.

I. Striz, E. Cecrdlova, A. Sekerkova, J. Slatinska, V. Svachova, O. Viklicky.
Seven Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients.

J. Leventhal,¹ J. Galvin,¹ D. Stare,¹ L. Gallon,¹ J. Miller,¹ J. Mathew,¹ M. Abecassis,¹ S. Ildstad.²
Share35 Liver Allocation Is Associated with Increased Early Graft Failure Rate.

T. Wong,¹ N. Koizumi,² J. Ortiz.³
Shifts of Etiology in Patients with in Bacteremic Liver Transplant Recipients.

S. Kim,¹ Y. Kim,¹ J. Choi,¹ S. Yoon,¹ G. Na,² J. Kim,² I. Moon,² Y. Yoo,² D. Kim.²
Short Duration Perioperative Administration of Ledipasvir/Sofosbuvir Is Safe and Effective in Preventing HCV Recurrence After Liver Transplant.

E. Verna,¹ J. Levitsky,² J. O'Leary,³ N. Bzowej,⁴ D. Moonka,⁵ R. Hyland,⁶ D. Brainard,⁶ J. McHutchison,⁶ N. Terrault.⁷
Short Term Changes in HRQOL Following Kidney Transplantation.

I. Olorundare, H. Ying, M. McAdams-DeMarco, D. Segev.
Short UK Dialysis Does Not Significantly Impact on Live Donor Kidney Allograft Survival.

A. Bentall,^1,2 M. Jesky,^1,2 R. Borrows,^1,2 R. Johnson,³ S. Ball.^1,2
Short-Term Post-Donation Renal Function in Living Kidney Donors.

L. Fahmy, A. Massie, A. Muzaale, S. Sandal, E. Chow, D. Segev.
Short-Term Starvation Attenuates Liver Ischemia Reperfusion Injury by SIRT1-Autophagy Signaling in Mice.

J. Rao,¹ H. Zhou,¹ F. Zhang,¹ X. Wang,¹ Y. Zhai,² L. Lu.¹
Short, Cool and Well Oxygenated – HOPE for DCD Kidneys.

P. Kron, A. Schlegel, O. de Rougemont, C. Oberkofler, P.-A. Clavien, P. Dutkowski.
Should HLA DR and DQ Eplet Mismatching Replace Traditional DR and DQ Mismatching for Deceased Donor Offers in Pediatric Renal Transplantation?

C. Bryan, V. Chadha, B. Warady.
Should Obese Patients Undergo Renal Transplantation? A Retrospective Analysis to Assess Whether Body Mass Index Can Affect Transplant Outcome.

A. Mehta,¹ A. Marriott,¹ A. Ghazanfar.²
Should Renin Angiotensin Blockade Be the Mainstay of Hypertension Treatment in Kidney Donors?

O. Sanchez, L. Ferrara, D. Berglund, S. Reule, R. Spong, N. Issa, A. Kukla, A. Matas, H. Ibrahim.
Significance of Preservation Fluid Cultures in Solid Organ Transplantation.

H. Nam, N. Perni, K. Galen, M. Campara, R. Roca-Garcia, V. Yeldandi.
Significant Association of Innate Immune Related Genes Polymorphism on Infectious Complications Following Early Post Renal Transplantation phase.

L. Das, K. Ide, Y. Tanaka, S. Shimizu, N. Tanimine, S. Verma, H. Ohdan.
Significant Association of Vitamin-D Receptor (VDR) Gene Polymorphism and Incidence of De Novo DSA in Renal Transplantation.

L. Das, K. Ide, Y. Tanaka, N. Tanimine, S. Verma, H. Ohdan.
Significant Increase in Wait List Removals for Candidates Considered Too Sick from the US Kidney Transplant Waiting List.

E. Poggio, L. Buccini, S. Flechner, D. Goldfarb, J. Schold.
Significant Pharmacokinetic Interaction Between Everolimus and Tacrolimus in De Novo Renal Transplant Recipients.

H.-P. Chang,¹ C.-Y. Lee,² C.-C. Si,¹ M.-K. Tsai,² F.-L. Lin Wu.^1,3
Signs of a Dying Organ: Beyond Resistance in Subnormothermic Kidney Perfusion.

M. Blum, D. Urcuyo, Q. Liu, B. Soliman, T. Okamoto, D. Goldfarb, C. Quintini.
Similar Kidney Allograft and Patient Survival in Native Americans Despite Lower Rates of Living Donation and Longer Wait on the Deceased Donor List.

H. Khamash,¹ K. Reddy,² H. Chakkera,¹ J. Huskey,¹ S. Sukumaran-Nair,¹ A. Mathur,² A. Moss,² N. Katariya,² A. Singer,² R. Heilman.¹
Simulating Alternative Bayesian Criteria to Identify Transplant Center Performance Outliers.

J. Schold,¹ C. Miller,¹ M. Henry,² L. Buccini,¹ S. Flechner,¹ D. Goldfarb,¹ E. Poggio,¹ K. Andreoni.³
Simultaneous En-Bloc Dual Transplantation: A New Approach.

D. Nghiem.
Simultaneous Pancreas and Kidney Transplantation for Type 2 Diabetes.

K. Wong, W. Bry, H. Mahanty, P. Patel.
Simultaneous Pancreas/Kidney Transplantation Increases the Risk of Late-Onset BKV-Associated Nephropathy.

T. Schachtner,^1,2 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2
Single Cell Profiling of Th9 Cells Allows Identification of Functionally Different Subsets.

K. Stanko, J. Schumann, K. Vogt, S. Schlickeiser, C. Appelt, B. Sawitzki.
Single Center Experience with Robotic Kidney Transplantation for Recipients with BMI >40 kg/m²: A Comparison with the UNOS Registry.

I. Tvetanov, S. Garcia Aroz, M. Spaggiari, J. Hoonbae, J. Oberholzer, E. Benedetti.
Sirolimus Regimen and Viral Serology as Risk Factors for Outcomes of Adult Kidney Transplants: 14-Year Cumulative Data in the United States.

A. Santos, M. Casey, X. Wen, S. Rehman, K. Womer.
Skin as a Harbinger of Rejection of Underlying Structures in Vascularized Composite Allografts: Concordance or Discordance?

L. Cendales,¹ M. Levine,² S. Bartlett,³ J. Cheeseman,¹ C. Drachenberg,³ W. Hancock,⁴ M. Joshi,¹ A. Kirk,¹ F. Leoopardi,¹ S. Levin,² M. Uluer,³ A. Selim,⁵ M. Song,¹ W. Twaddell,³ L. Wang,⁴ Z. Wang,² R. Barth.³
Skipping Comparable Local Waitlist Candidates Under Share 35.

E. Chow,¹ A. Massie,¹ X. Luo,¹ C. Wickliffe,¹ S. Gentry,² A. Cameron,¹ D. Segev.¹
Slipping Through the Cracks: Late Onset BK Viremia.

J. Gandhi,¹ M. Mackenzie,¹ D. DeWolfe,² F. Cardarelli,³ M. Pavlakis,³ C. Tan.^1,4
SLPI in the Perfusion Liquid: A Predictor Marker of Short and Long Term Clinical Outcomes.

A. Dotta,¹ F. Caro,² K. Peña Ponce,¹ N. Ambrosi,² J. Salaberry,² X. García,¹ E. Minué,¹ L. León,¹ F. Sánchez,² F. Togniolo,¹ C. Incardona,³ E. Chuluyan,² D. Casadei.¹
Smoking Exposure Among Kidney Allograft Recipients and Outcomes After Transplant.

H. Gillott,¹ S. Tahir,¹ F. Jackson-Spence,¹ F. Evison,² J. Nath,³ A. Sharif.³
Social Support Does Not Predict Medication Adherence Post-Transplantation: A Systematic Review and Meta-Analysis.

K. Ladin,¹ A. Daniels,¹ R. Bannuru,² M. Osani.²
Sociodemographic and Comorbidity Differences Between Dialysis, Waitlisted and Transplant Patients in the UK: Findings from the ATTOM Study.

D. Wu,¹ M. Robb,² C. Watson,³ R. Ravanan,⁴ J. Forsythe,¹ A. Bradley,³ G. Oniscu.¹
Socioeconomic Status and Readmission Following Kidney Transplant.

S. DiBrito, E. King, M. O'Hare, D. Segev.
Sofosbuvir-Based Regimen in Treatment Experienced-Post Liver Transplant Patients with Hepatitis C Recurrence.

A. Ajlan,¹ A. Aljedai,¹ H. Elsiesy,² D. Alkortas,¹ R. Alarieh,² W. Alhumodi,² D. Broring,² M. Alsebayel,² F. Aba Alkhail.²
Solid Phase Assay Demonstrates High Rates of Allosensitization in Pediatric Heart Recipients.

W. Zuckerman,¹ B. Feingold,² A. Zeevi,² C. Bentlejewski,² L. Addonizio,¹ E. Blume,³ C. Canter,⁴ A. Dipchand,⁵ D. Hsu,⁶ R. Shaddy,⁷ W. Mahle,⁸ K. Much,⁹ B. Armstrong,⁹ D. Ikle,⁹ H. Diop,¹⁰ J. Odim,¹⁰ S. Webber.¹¹
Soluble Fibrinogen-Like Protein 2 Regulates Differentiation and Enhances Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Allograft Immunity.

C. Yang,^1,4 L. Wang,³ R. Rong,^2,4 T. Zhu,^2,4 M. Xu.^2,4
Soluble ST2 and Cardiovascular (CV) Outcomes and Mortality in Kidney Transplant Candidates.

M. Keddis,¹ Z. El-Zoghby,² A. Gray,² J. Meeusen,² L. Donato,² F. Cosio,² D. Steidley.¹
Some DCD Livers Function as Well as DBD Livers: The Implications of Discarding Usable Livers.

J. Scalea, R. Redfield, D. Foley.
Sphingosine 1-Phosphate (S1P) Receptors Differentially Regulate Murine and Human CD4 T Cell Migration Across Lymphatic Endothelium.

Y. Xiong,¹ C. Brinkman,¹ K. Hippen,² B. Blazar,² J. Bromberg.¹
Sphingosine-1 Phosphate Receptor 1 Agonist SEW2871 Ameliorates Hepatocellular Injury on Ischemic Reperfusion in Mice: A New Therapeutic Target.

T. Ito, N. Kuriyama, A. Matsuda, H. Kato, Y. Iizawa, Y. Murata, A. Tanemura, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji.
Standard Dose Valganciclovir Prophylaxis for High-Risk Kidney Transplant Recipients Reduces Incidences of Breakthrough and Resistant Cytomegalovirus Infection.

Y. Huang, J. Park, A. Naik, D. Kaul.
Standardized Pre-Implantation Kidney Biopsies of Expanded Criteria Donors to Improve the Kidney Donor Profile Index (KDPI) for the Evaluation of Marginal Donors.

A. Sánchez-Escuredo,¹ A. Sagasta,² F. Diekmann,¹ I. Revuelta,¹ L. Rodas,¹ D. Paredes,³ M. Musquera,⁴ N. Esforzado,¹ M. Ricart,¹ F. Cofan,¹ V. Torregrosa,¹ J. Campistol,¹ M. Sole,² F. Oppenheimer.¹
Stem Cell-Mediated Regeneration of Ischemically Damaged Renal Allografts During Ex Vivo Warm Perfusion.

L. Brasile,¹ N. Henry,¹ B. Stubenitsky.²
Steroid Free Immunosuppression and Clinical Outcomes in Recipients of Deceased Donor Kidney Transplant with Positive Flow Cytometry Crossmatch.

O. Adebiyi, T. Taber, W. Goggins, D. Mishler, M. Yaqub, A. Sharfuddin.
Steroid Use May Not Increase Risk of Fracture in Kidney Transplant Patients.

N. Sarabu, K. Kucharski, D. Hricik, A. Padiyar, A. Huml, J. Augustine.
Storage Kidneys Prior to Transplantation Using First Polish Preservation Solution "Biolasol" – Preliminary Report.

A. Jozwik,¹ P. Domagala,¹ R. Kieszek,¹ M. Wszola,¹ M. Bieniasz,¹ M. Serwanska-Swietek,¹ M. Durlik,² F. Ryszka,³ A. Chmura,¹ A. Kwiatkowski.¹
Strategies to Prevent Ischemic Cholangiopathy After Donation After Circulatory Death Donor Liver Transplantation.

C. Kubal,¹ R. Mangus,¹ J. Fridell,¹ B. Ekser,¹ N. Rush,² R. Saxena,² J. Tector.¹
Stratification of Kidney Transplant Recipients into Those with Low and High Alloreactive T-Cells May Allow Safe Conversion to mTOR-Inhibitor-Based Immunosuppression.

T. Schachtner,^1,2 M. Stein,² P. Reinke.^1,2
Stratifying Skin Versus Non-Skin Cancer Risk Post-Kidney Transplantation According to Patient Characteristics.

F. Jackson-Spence,¹ H. Gillott,¹ S. Tahir,¹ F. Evison,² J. Nath,³ A. Sharif.³
Stress Cardiomyopathy in the Perio-Perative Period After Liver Transplant.

N. Presser, B. Barzilai.
Subclinical Cytomegalovirus Viraemia in Renal Transplant Recipients.

K. Barker,¹ N. Cook,¹ P. Kevan,² I. Frank.¹
Sublingual Tacrolimus in Liver Transplantation: A Valid Option?

M. Moreno Gonzales,¹ L. Myhre,² T. Taner.¹
Subnormothermic Machine Perfusion (SNMP) Leads to Increased Bile Production and Secretion of Hydrophilic Bile Acids After Liver Transplantation When Compared to Cold Storage (CS).

B. Banan, R. Lopez, Z. Khan, C. Hughes, G. Michalopoulos, P. Fontes.
Subnormothermic Machine Perfusion (SNMP) of Liver Allografts with a Novel Hemoglobin-Based Oxygen Carrier (HBOC) Increases β-Oxidation of Fatty Acids and Decreases Lipid Peroxidation (LP).

B. Banan, R. Lopez, C. Hughes, G. Michalopoulos, P. Fontes.
Subnormothermic Machine Perfusion (SNMP) with a Hemoglobin Based Oxygen Carrier (HBOC) Solution Reprograms Dynamic Inflammation Networks When Compared to Cold Storage (CS) in a Porcine Liver Allograft Model.

D. Sadowsky, R. Zamora, B. Banan, D. Barclay, J. Yin, Y. Vodovotz, P. Fontes.
Subnormothermic Machine Perfusion (SNMP) with a Novel Hemoglobin-Based Oxygen Carrier (HBOC) Solution for Ex Vivo Preservation in Vascularized Composite Allotransplantation (VCA).

S. Oksuz, R. Schweizer, M. Minervini, B. Banan, V. Gorantla, P. Fontes.
Subtype-Compatible (A2/A2B–>B) Transplantation Under KAS Increases Access 3-Fold for Blood Type B Patients, yet Very Few Candidates Are Listed as Eligible.

D. Stewart,¹ W. Cherikh,¹ A. Kucheryavaya,¹ C. Bryan,² N. Turgeon,³ M. Aeder.⁴
Successful Human-to-NonHuman Primate Pancreatic Islet Intraportal Xenotransplantation Using a Human Allo-Based Immunosuppression Regimen and Its Potential Pre-Clinical Application.

J. McGarrigle,¹ M. Bochenek,¹ E. Marchese,¹ A. Khan,¹ D. Gutierrez,^1,2 A. Mikalauskaite,¹ B. McCracken,¹ M. Reedy,¹ M. Omami,¹ C.-C. Yeh,¹ M. Spaggiari,¹ M. Nourmohammadzadeh,^1,2 D. Isa,¹ S. Ghani,¹ L.-J. Wang,¹ J. Mendoza-Elias,^1,2 Y. Wang,¹ J. Oberholzer.^1,2
Successful Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors.

C. Ensor, R. Winstead, B. Johnson, M. Morrell, S. Kilaru, C. Moore, J. Hayanga, A. Zeevi, E. Lendermon, J. McDyer.
Successful Prophylactic Use of Eculizumab in aHUS Kidney Transplant Patients: A Report of 9 Cases.

A. Kumar,¹ Z. Stewart,³ A. Reed,³ D. Orozco,² R. Smith,^1,2 C. Nester,^1,2 C. Thomas.^1,2
Successful Transplantation in ABO- and HLA-Incompatible Kidney-Transplant Patients.

L. Rostaing, N. Congy, A. Allal, L. Esposito, F. Sallusto, N. Congy, X. Doumerc, B. Debiol, N. Kamar.
Successful Treatment of Established Acute Allograft Rejection with Delayed CTLA-4Ig.

J. Young,¹ J. Chen,¹ D. Yin,¹ R. Sciammas,² V. Vu,¹ M.-L. Alegre,³ A. Chong.¹
Successful Treatment of Hepatitis C in Renal Transplant Recipients with Directly Acting Antiviral Agents.

M. Lubetzky,¹ S. Chun,¹ A. Joelson,¹ E. Akalin,¹ P. Gaglio,² G. DeBoccardo.¹
Sudden Increase in Allocation Score for Pediatric Liver Transplant Candidates Predicts Waitlist Mortality.

X. Luo, D. Mogul, A. Massie, D. Segev.
Superior Waitlist and Equivalent Transplant Outcomes Among Hepatitis C RNA-Positive Patients Who Are Willing to Accept Hepatitis C Seropositive Kidneys.

J. Sageshima,¹ A. de Mattos,² C. Troppmann,¹ C. Santhanakrishnan,¹ J. McVicar,¹ B. Gallay,² M. Gandhi,² M. Alnimri,² R. Perez.¹
Surgical Site Infection Does Not Fully Explain the Impact of Obesity on Post-Transplant Outcomes.

S. Bae, L. Kucirka, A. Massie, D. Segev.
Surgical Techniques in Modified Multiorgan Transplantation.

W. Ju, J. Lin, J. Zhou, M. Chen, A. Yang, D. Wang, Y. Ma, Z. Guo, M. Han, X. Wang, X. Zhu, X. He.
Surveillance Biopsy Findings with Alemtuzumab (ALZ) Induction in Kidney Transplantation.

H. Madariaga,¹ R. Ugarte,¹ C. Drachenberg,² N. Costa,¹ B. Thomas,¹ J. Bromberg,³ M. Weir,¹ A. Haririan.¹
Surveillance Renal Allograft Biopsies Prognosticate Graft Function.

J. Thompson, D. Taber, P. Baliga, K. Chavin, T. Srinivas.
Survey Results Show Strong Support for Allowing Patients Undergoing Desensitization to Keep Their Pre-Desensitization CPRA Allocation Priority.

A. Kucheryavaya,¹ R. Bray,² D. Tyan.³
Survival Advantage in the Elderly with Kidney Transplantation.

G. Spanos,¹ N. Duncan,¹ P. Brookes,¹ D. Goodall,¹ K. Koutroutsos,¹ E. Evangelou,² M. Loucaidou.¹
Survival Advantage with Older Live Donor Compared to Standard Criteria Deceased Donor Kidney Transplantation in Older Recipients.

P. Abrams, M. Cooper, J. Verbesey, R. Ghasemian, M. Grafals, A. Gilbert, J. Moore, J. Fenton, C. Cannon, J. Rapisurra, B. Javaid.
Survival After Second Kidney Transplant: Are We Being Good Stewards?

C. Jay, J. Pugh, G. Halff, G. Abrahamian, F. Cigarroa, N. Stephens, K. Washburn.
Survival Benefit from Kidney Transplantation Using Kidneys from Deceased Donors Over 75 Years.

M. Pérez-Sáez,¹ E. Arcos,² J. Comas,² M. Crespo,¹ J. Lloveras,¹ J. Tort,² J. Pascual,¹ Catalan Renal Registry Committee.²
Survival Benefit of DCD Livers.

X. Luo, A. Massie, D. Segev.
Survival Benefit of High-KDPI Kidneys Among Obese Transplant Candidates.

M. Bowring, A. Massie, X. Luo, D. Segev.
Survival Benefit of Kidney Transplantation in US Adults with Sickle Cell Nephropathy.

T. Purnell, X. Luo, S. Bae, A. Massie, D. Segev.
Survival Benefit of Living Donor ABOi Kidney Transplantation.

A. Massie, B. Lonze, S. Anjum, X. Luo, D. Segev.
Susceptibility Patterns of Pre-Transplant Pseudomonas and Post-Lung Transplant Outcomes in Patients with Cystic Fibrosis.

S. Pouch,¹ E. Lease,² T. Bogdanovich,³ D. Ho,⁴ R. Miller,⁵ M. Estabrook,⁶ T. Babu,⁷ C. Kotton,⁷ C. Shaver,⁸ L. Thomas,⁸ S. Aslam,⁹ T. McCarty,¹⁰ J. Garcia-Diaz,¹¹ K. Doucette,¹² S. Kirkby,¹³ D. van Duin.¹⁴
Systematic Pathological Component Scores for Skin-Containing Vascularized Composite Allografts.

I. Rosales,¹ M. DeFazio,² R. Foreman,¹ D. Sachs,² C. Cetrulo,² D. Leonard,^2,3 R. Colvin.¹
Systematic Review and Meta-Analysis of the Impact of Computed Tomography Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation.

J. van Vugt,¹ S. Levolger,¹ R. de Bruin,¹ J. van Rosmalen,² H. Metselaar,³ J. IJzermans.¹

Jump to: View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z